Evexia Lifecare Share Price

Evexia Lifecare Limited, with its corporate operations in Ahmedabad, functions as a diversified healthcare company in India . The company engages in trading of pharmaceutical chemicals, operating retail pharmacy services, providing diagnostic solutions, and manufacturing plastic granules through reprocessing . Evexia Lifecare has a presence in domestic markets and has been operating for over a decade in the trading of industrial chemicals . 

Evexia Lifecare share price on NSE and BSE signifies how market participants react to the company’s operational performance and the overall developments in the healthcare and chemical sectors. The company’s financial health depends on factors like pharma chemical trading volumes, retail pharmacy sales, diagnostic service demand, and the company’s ability to manage operational costs. Evexia Lifecare stock price gets influenced by various factors such as earnings reports, changes in government pharmaceutical policies, and trends in chemical and healthcare product demand. In the longer run, strategies such as expansion into manufacturing of plastic granules, personalized healthcare solutions, and diagnostic service growth affect the stock market sentiments. All these factors need monitoring to have an idea about the company’s stock price movements. 

Evexia Lifecare live share price provides real-time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of the Evexia Lifecare stock price movements helps in observing short term price volatility and shows how a stock moves relative to the broader healthcare index. Furthermore, monitoring Evexia Lifecare live price helps investors understand real-time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short-term performance and respond to news, quarterly results, or sector trends that may influence the company’s valuation. 

EVEXIA LIFECARE COMPANY FUNDAMENTALS 

(A) Company Background 

Evexia Lifecare Limited was incorporated on 23 November 1990 in Vadodara, Gujarat, India. The company was formerly known as Kavit Industries Limited and later rebranded as Evexia Lifecare Limited in January 2021. It is listed on the Bombay Stock Exchange (BSE). The company has evolved from its earlier petrochemical-related operations to a diversified business model, with activities including trading of chemicals, agricultural products, and consumer goods. In recent years, it has undertaken a strategic shift toward the pharmaceutical sector, particularly in trading pharmaceutical chemicals and expanding through acquisitions and investments.  

(B) Company Product Lines 

• Chemical Products  
  • Industrial chemicals, specialty chemicals, solvents, and petrochemical-related products  

• Pharmaceutical Chemicals  
  • Trading of pharmaceutical and healthcare-related chemical products  

• Agricultural and Consumer Goods  
  • Edible oils and other agro-based commodities  

• Metals and Commodities  
  • Trading in gold, diamonds, and related commodities  

• Other Products and Services  
  • Plastic granules and lubricants  
  • Software, mobile application, and website development services  
  • Electric bikes (e-bike related activities)  

(C) Company Revenue Model 

• Trading Activities:  
  • Revenue generated from trading of chemicals, agro products, metals, and consumer goods  

• Pharmaceutical Segment:  
  • Income from trading pharmaceutical chemicals and related products  

• Diversified Product Sales:  
  • Revenue from multiple product categories including industrial inputs and commodities  

• Other Business Activities:  
  • Earnings from services such as software development and emerging segments like e-bikes  

(D) Geographic Presence 

• Headquarters:  

• • Vadodara, Gujarat, India  

• Domestic Operations:  

• • Trading and business activities primarily across India  

• International Linkages:  

• • Engagement in trading activities involving global commodity markets (import/export linkages through trading operations)  

(E) Company Key Milestones 

• 1990: Incorporation of the company in Vadodara, India  

• 1994: Listing on the Bombay Stock Exchange (BSE)  

• 2021: Name change from Kavit Industries Limited to Evexia Lifecare Limited  

• 2022–2023: Fundraising initiatives including issuance of FCCBs for expansion  

• Recent Years: Strategic shift toward pharmaceutical chemicals and acquisitions to expand business operations  

(F) Company Industry Perspective 

The company operates in a diversified trading and chemicals industry, which includes segments such as petrochemicals, pharmaceutical chemicals, and agro commodities. These sectors are influenced by raw material availability, regulatory policies, and demand from end-use industries such as manufacturing, healthcare, and agriculture. 

The pharmaceutical chemicals segment is driven by demand from the healthcare sector and supply chain requirements of pharmaceutical manufacturers. Commodity trading businesses are subject to price fluctuations, currency movements, and global demand-supply conditions. 

Within this environment, Evexia Lifecare Limited operates as a diversified trading entity with activities across multiple product categories, with recent strategic focus on pharmaceutical-related operations. 

Evexia Lifecare Stock Market Presence: Listings & Index Representation 

Evexia Lifecare Limited is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). Evexia Lifecare share price is available for trading on the NSE under the symbol EVEXIA and on the BSE with the scrip code 543444 . The company’s market presence is primarily within the small-cap segment of the market . Due to its size and sector focus, Evexia Lifecare stock price is generally tracked by investors interested in the healthcare and chemical trading industry. 

Evexia Lifecare is part of several broad-based and sector-specific stock market indices, reflecting its position as a small-cap diversified company in India. Evexia Lifecare share price is a constituent of wider market indices such as the BSE SmallCap index. In addition, the company is included in multiple BSE indices which capture companies across small and mid-cap segments. 

Evexia Lifecare Stock Performance and Share Price History 

Evexia Lifecare share price on NSE reflects its status as a diversified healthcare company with a focus on pharmaceutical chemical trading and plastic reprocessing in India. Performance gets driven by factors like pharma chemical trading volumes, diagnostic service demand, plastic granule production capacity utilization, and the company’s ability to manage operational costs effectively . Investors compare Evexia Lifecare share price today with other healthcare and chemical companies to gauge relative performance within the sector. 

These underlying factors often appear through real market movements across different periods. Broader sector strength has played a role in supporting Evexia Lifecare share price. In addition to operational and sector-led factors, corporate actions such as the company’s expansion into plastic reprocessing can also have a significant impact on Evexia Lifecare share price movements. The company entered into manufacturing of plastic granules in December 2019 as part of its expansion program . This shows how corporate actions can trigger short-term swings, even within a competitive healthcare and chemical framework influenced by regulatory policies and demand cycles. 

While short-term movements reflect events and announcements, longer-term valuation trends become visible through Evexia Lifecare share price 52-week high and low, providing context beyond daily or weekly changes . Highs indicate strong trading volumes and stable margins, while lows align with market corrections or sector volatility . These levels capture the impacts of government policies, healthcare demand, and earnings visibility, providing context for the stock’s historical performance. 

Evexia Lifecare stock performance reflects the trading behaviour of a small-cap diversified company operating within India’s competitive healthcare and chemical landscape. The company’s operations across pharma chemical trading, retail pharmacy, diagnostic solutions, and plastic reprocessing have shaped its Evexia Lifecare share price history. Over time, the stock has shown periods of growth and phases of consolidation. The company has been trading pharmaceutical chemicals for over a decade . 

Evexia Lifecare stock performance over time has closely followed India’s healthcare demand and chemical trading cycles. The company’s trading business contributes a significant portion of its revenue . Over longer investment horizons, the stock has delivered mixed returns, with a one-year return showing a decline . The stock reached a 52-week high at a certain level and a 52-week low at a different level, reflecting the volatility inherent in the trading business . 

Despite the disruptions caused by the COVID-19 pandemic, Evexia Lifecare shares faced challenges during that period as supply chains were disrupted and demand patterns shifted. The company’s operations were impacted by lockdowns and reduced economic activity. The company has been working on expanding its product portfolio and exploring new business verticals. 

Evexia Lifecare share price has seen decreases due to several recurring reasons. A decline in pharma chemical trading volumes directly impacts revenue and leads to selling pressure. Changes in government policy, such as alterations in chemical import duties or changes in pharmaceutical regulations, can also cause the stock to fall. Furthermore, any increase in operational costs like raw material procurement costs without a matching rise in selling prices squeezes the company’s margins, making the stock less attractive. Periods of economic slowdown that reduce healthcare spending raise concerns about demand, leading to a drop in Evexia Lifecare share price. The stock is also sensitive to competitive intensity in the chemical trading space; if larger players gain market share, it can lead to a decrease in Evexia Lifecare stock price as investors adjust expectations for future revenue growth. Broader market sell-offs in small-cap healthcare stocks also pull the price down, regardless of the company’s individual performance. The company reported a net profit of over three crore rupees for the third quarter of financial year 2026, showing a decline compared to the previous quarter . A decrease in diagnostic service revenue or lower plastic granule sales directly hurts the company’s revenue, resulting in a lower valuation for Evexia Lifecare share price. 

Evexia Lifecare Investor Relevance and Role in Portfolio 

Evexia Lifecare is a holding in healthcare and small-cap portfolios, offering exposure to pharma chemical trading, retail pharmacy, diagnostic solutions, and plastic reprocessing. Inclusion in small-cap indices underscores its importance in India’s diversified healthcare space. The company’s diversified business model and expansion into new verticals make it a consideration for certain allocations. 

Evexia Lifecare equity is held by a broad mix of promoters and public shareholders, reflecting its standing in India’s healthcare sector. Promoter holding remains stable at around sixty percent . Foreign institutional investors hold a nominal percentage of the company’s shares . Public and retail investors hold approximately thirty nine percent of the company’s shares . This broad investor base with promoter control underscores the company’s role as a holding in both domestic and global portfolios focused on diversified healthcare services. 

Beyond fundamentals and ownership, Evexia Lifecare share price is actively monitored by market participants. The stock is available for trading on the NSE and BSE, and market participants watch price movements to gauge sentiment around quarterly results and policy announcements. 

Technical indicators such as RSI, MACD, and MFI provide additional insight into short-term momentum shifts in the company’s stock price. While these indicators are primarily used for near-term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements. 

Evexia Lifecare stock price has exhibited certain volatility patterns. Evexia Lifecare beta has generally remained at levels reflecting its position as a small-cap diversified stock with promoter control and business fundamentals tied to chemical trading and healthcare cycles. Over shorter timeframes, the stock has shown relatively higher sensitivity to market movements, indicating short-term volatility. During the three-month period, this sensitivity appears more balanced, suggesting a stable trading pattern. Across longer durations, the beta trends in a manner indicating continued correlation with overall market fluctuations. This behaviour is typical for companies in the trading sector with exposure to commodity price cycles. Overall, these variations across different timeframes highlight that while Evexia Lifecare may experience short-term fluctuations, its longer-term volatility remains characteristic of a small-cap diversified stock. 

Evexia Lifecare Sectoral Relevance and Peer Positioning 

Evexia Lifecare sector relevance stems from its scale in pharma chemical trading and its presence across retail pharmacy, diagnostic solutions, and plastic reprocessing segments . Peer comparisons with companies like Divi’s Laboratories, Torrent Pharmaceuticals, and other pharmaceutical trading companies focus on trading volumes, product diversification, service breadth, and geographical presence rather than short-term stock moves . These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of pharmaceutical demand, chemical price cycles, and healthcare spending further highlights Evexia Lifecare positioning within India’s broader healthcare and chemical trading market. 

Evexia Lifecare market cap history shows the company’s position within the healthcare sector. Since its incorporation, the market capitalization has grown as the company expanded its trading operations and entered new business verticals . The company’s focus on diversification into plastic reprocessing and diagnostic solutions has influenced market perception. This transition from a pure trading company to a diversified healthcare and manufacturing entity has been a key factor in how the company’s overall valuation has evolved over time. The company currently maintains a market capitalization in the small-cap range . 

Evexia Lifecare earnings history demonstrates the impact of its strategic business decisions and external market conditions. The company reported total revenue of over one hundred eighty nine crore rupees for the financial year 2025, with net profit of over four crore rupees . For the third quarter of financial year 2026, the company reported revenue of over forty nine crore rupees, with net profit of over three crore rupees . The company’s net profit margin for the trailing twelve months stood at over two percent . The company’s operating profit margin for the financial year 2025 stood at over five percent . 

Evexia Lifecare EPS provides insight into its operational performance and income generation from pharma chemical trading and other services. Over the years, earnings per share have shown variation in line with the company’s business cycle and industry conditions. The company’s focus on expanding into plastic reprocessing and personalized healthcare solutions has influenced the EPS trajectory. Quarterly performance reflects the ongoing earnings from trading and service operations, with the pharma chemical segment contributing to the overall per-share earnings picture. The company’s basic earnings per share for the trailing twelve months was reported at over zero rupees forty paise . 

Evexia Lifecare P/E ratio reflects how investors perceive the company’s earnings relative to its business model. The company’s price-to-earnings ratio has been observed around fourteen to eighteen times, indicating the valuation the market assigns to the company’s earnings . This ratio has moved in response to how investors view the company’s prospects in areas like plastic granule manufacturing and diagnostic service expansion. The company’s P/E ratio has fluctuated based on earnings performance and market sentiment, with the ratio reported at fourteen point six times on certain data . These changes highlight how market sentiment has evolved alongside the company’s business transformation and expansion strategy. 

Summary 

Evexia Lifecare Limited trades pharmaceutical chemicals, operates retail pharmacies, provides diagnostic solutions, and manufactures plastic granules. Evexia Lifecare share price on the NSE and BSE reflects trading activity within the diversified healthcare and chemical trading industry. The company has a notable presence in domestic markets. Evexia Lifecare stock price is influenced by chemical trading volumes, healthcare demand, regulatory changes, and broader economic factors. The company’s focus on diversification and expansion remains a key aspect of its business profile .